| NCT05581550 | National Cancer Centre, Singapore|National Cancer Centre Research Fund | Nasopharyngeal Cancer|Epstein-Barr Virus Related Carcinoma | 2020-06-29 | NA |
| NCT02812849 | Rigshospitalet, Denmark | Cardiac Sarcoidosis | 2016-06 | |
| NCT02019706 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | ACTH|Cushing´s Syndrome | 2014-02-12 | PHASE2 |
| NCT07150546 | Emory University|National Cancer Institute (NCI) | Digestive System Neuroendocrine Tumor|Unresectable Digestive System Neuroendocrine Neoplasm|Unresectable Digestive System Neuroendocrine Tumor G1|Unresectable Digestive System Neuroendocrine Tumor G2 | 2025-10-14 | PHASE1 |
| NCT04029428 | University of Warmia and Mazury|Stowarzyszenie Pacjentów i Osób Wspieraj?cych Chorych na Guzy Neuroendokrynne | Neuroendocrine Tumors | 2004-11-02 | PHASE2 |
| NCT04074135 | National Cancer Institute (NCI) | VHL Pancreatic Neuroendocrine Tumors|Von Hippel-Lindau Disease|Neuroendocrine Tumors | 2020-06-02 | PHASE2 |
| NCT02174679 | Jonsson Comprehensive Cancer Center | Carcinoid Cancer|Neuroendocrine Tumors|Medullary Thyroid Cancer|Cancers Expressing Somatostatin Receptors | | |
| NCT03746847 | University of Pennsylvania|Advanced Accelerator Applications | Cardiac Sarcoidosis | 2018-12-01 | |
| NCT01099228 | David Bushnell|VA Office of Research and Development | Neuroendocrine Tumors | 2006-09 | NA |
| NCT00001160 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Hurthle Cell Thyroid Cancer|Tall Cell Variant Thyroid Cancer|Follicular Thyroid Cancer|Thyroid Cancer|Papillary Thyroid Cancer | 1977-06-01 | |
| NCT05724108 | National Cancer Institute (NCI) | Metastatic Neuroendocrine Tumor | 2023-08-30 | PHASE2 |
| NCT07150806 | Joshua Palmer|RayzeBio, Inc. | Recurrent Meningioma | 2025-11-12 | PHASE1|PHASE2 |
| NCT06016855 | Vanderbilt-Ingram Cancer Center | Digestive System Neuroendocrine Tumor G1|Digestive System Neuroendocrine Tumor G2|Metastatic Digestive System Neuroendocrine Neoplasm|Metastatic Malignant Neoplasm in the Liver|Pancreatic Neuroendocrine Tumor G1|Pancreatic Neuroendocrine Tumor G2 | 2024-05-31 | PHASE4 |
| NCT05773274 | National Cancer Institute (NCI) | Metastatic Digestive System Neuroendocrine Tumor G1|Metastatic Digestive System Neuroendocrine Tumor G2|Unresectable Digestive System Neuroendocrine Tumor G1|Unresectable Digestive System Neuroendocrine Tumor G2 | 2024-01-12 | PHASE2 |
| NCT05247905 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Metastatic Pancreatic Neuroendocrine Tumor|Unresectable Pancreatic Neuroendocrine Carcinoma | 2023-02-16 | PHASE2 |
| NCT05691465 | National Cancer Institute (NCI) | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation|Metastatic Prostate Neuroendocrine Carcinoma|Metastatic Prostate Small Cell Neuroendocrine Carcinoma|Stage IV Prostate Cancer AJCC v8 | 2023-12-27 | PHASE2 |
| NCT03580161 | Royal Marsden NHS Foundation Trust | Exposure to Medical Diagnostic Radiation | 2018-06-30 | |
| NCT03873870 | University Health Network, Toronto | Neuroendocrine Tumors | 2019-03-28 | NA |
| NCT06359054 | Celal Bayar University | Breast Cancer | 2020-11-11 | NA |
| NCT04750954 | National Cancer Institute (NCI) | Neuroendocrine Neoplasm | 2021-07-22 | PHASE1 |
| NCT05583708 | Weill Medical College of Cornell University|Hoosier Cancer Research Network | Merkel Cell Carcinoma | 2023-08-03 | PHASE2 |
| NCT06395402 | University of Iowa|Novartis | Neuroendocrine Tumors|Neuroendocrine Tumor Grade 1|Neuroendocrine Tumor Grade 2 | 2024-05-03 | PHASE2 |
| NCT04298541 | Weill Medical College of Cornell University|Cornell University | Meningioma | 2026-06 | PHASE2 |
| NCT06392815 | Rigshospitalet, Denmark | Borrelia Burgdorferi Neuroborreliosis | 2024-05-20 | NA |
| NCT04665739 | National Cancer Institute (NCI) | Advanced Lung Neuroendocrine Tumor|Functioning Lung Neuroendocrine Tumor|Locally Advanced Lung Neuroendocrine Neoplasm|Lung Neuroendocrine Neoplasm|Lung Neuroendocrine Tumor G1|Lung Neuroendocrine Tumor G2|Metastatic Lung Neuroendocrine Neoplasm|Metastatic Lung Neuroendocrine Tumor|Non-Functioning Lung Neuroendocrine Tumor|Recurrent Lung Neuroendocrine Neoplasm|Unresectable Lung Neuroendocrine Neoplasm|Unresectable Lung Neuroendocrine Tumor | 2023-02-03 | PHASE2 |
| NCT04609592 | Stanford University|Novartis Pharmaceuticals | Gastroenteropancreatic Neuroendocrine Tumor | 2021-03-17 | PHASE1 |
| NCT07185672 | Tata Memorial Hospital | Neuroendocrine Neoplasia´s (NENs)|Neuroendocrine Tumor GEP Grade 1-3|Neuroendocrine Gastroenteropancreatic Tumour | 2019-08-07 | PHASE3 |
| NCT02546388 | Marcelo F. Di Carli, MD, FACC|Mallinckrodt | Sarcoidosis | 2015-10 | NA |
| NCT04234568 | National Cancer Institute (NCI) | Metastatic Digestive System Neuroendocrine Neoplasm|Metastatic Neuroendocrine Tumor | 2020-07-20 | PHASE1 |
| NCT06121271 | University College, London | Bronchial and Thymic Neuroendocrine Tumour|Paraganglioma+ Phaeochromocytoma|Medullary Thyroid Carcinoma|Those Requiring Repeat Peptide Receptor Radionuclide Therapy | 2023-12-18 | PHASE2 |
| NCT05880394 | Hoag Memorial Hospital Presbyterian | Breast Cancer Stage IV | 2023-01-10 | PHASE2 |
| NCT02125474 | Instituto Nacional de Cancerologia, Columbia | Neuroendocrine Tumors | 2013-11 | NA |
| NCT04040166 | University Health Network, Toronto | Head & Neck Cancer | 2019-08-22 | NA |
| NCT01967537 | National Cancer Institute (NCI) | Neuroendocrine Tumors|Von Hippel-Lindau Syndrome|Hippel-Lindau Disease | 2013-10-18 | PHASE2 |
| NCT05687123 | National Cancer Institute (NCI) | Metastatic Pancreatic Neuroendocrine Tumor|Pancreatic Neoplasm|Stage III Pancreatic Neuroendocrine Tumor AJCC v8|Stage IV Pancreatic Neuroendocrine Tumor AJCC v8|Unresectable Pancreatic Neuroendocrine Tumor | 2024-08-14 | PHASE1 |
| NCT04529044 | OHSU Knight Cancer Institute|Advanced Accelerator Applications|Oregon Health and Science University|Novartis Pharmaceuticals | Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Recurrent Breast Carcinoma | 2025-12-01 | PHASE2 |
| NCT05816720 | Novartis Pharmaceuticals | Neuroendocrine Tumor | 2021-09-01 | |
| NCT04334837 | Curium US LLC | Neuroendocrine Tumors | | |
| NCT04106843 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Locally Advanced Adrenal Gland Pheochromocytoma|Locally Advanced Paraganglioma|Metastatic Adrenal Gland Pheochromocytoma|Metastatic Paraganglioma|Metastatic Parathyroid Gland Carcinoma|Pituitary Gland Carcinoma|Somatostatin Receptor Positive|Stage III Thyroid Gland Medullary Carcinoma AJCC v8|Stage IV Thyroid Gland Medullary Carcinoma AJCC v8|Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8|Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8|Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8|Unresectable Adrenal Gland Pheochromocytoma|Unresectable Paraganglioma | 2019-06-13 | PHASE2 |
| NCT04086485 | National Cancer Institute (NCI) | Gastroenteropancreatico Tumors|Neuroendocrine Tumors|Neuroendocrine Neoplasms | 2022-10-03 | PHASE1|PHASE2 |
| NCT03623984 | University of Alabama at Birmingham | Neuroendocrine Carcinoma of Pancreas|Carcinoid | 2019-06-07 | EARLY_PHASE1 |
| NCT06398444 | Sinotau Pharmaceutical Group | Advanced Neuroendocrine Neoplasm | 2024-06-11 | PHASE2|PHASE3 |
| NCT05884255 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Gastroenteropancreatic Neuroendocrine Tumor | 2023-07-06 | PHASE3 |
| NCT05459844 | Sinotau Pharmaceutical Group | Neuroendocrine Tumors | 2022-08-31 | PHASE3 |
| NCT05894486 | Peking University | Neuroendocrine Tumors | 2023-06-05 | PHASE2 |